Compounds > platinum
Page last updated: 2024-08-22

platinum and Invasiveness, Neoplasm

platinum has been researched along with Invasiveness, Neoplasm in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (15.38)18.2507
2000's1 (3.85)29.6817
2010's15 (57.69)24.3611
2020's6 (23.08)2.80

Authors

AuthorsStudies
Attwood, K; Cao, Q; Chatta, G; Goodrich, DW; Guru, KA; Katsuta, E; Li, QJ; Smith, GJ; Takabe, K; Wang, J; Wang, L; Wei, L; Wu, Y; Xu, B; Xu, D1
Alati, A; Bibault, JE; Charles-Nelson, A; Durdux, C; Fabiano, E; Geiss, R; Giraud, P; Housset, M; Kreps, S; Mareau, A; Méjean, A1
Albisinni, S; Mjaess, G; Pochet, C; Quackels, T; Roumeguère, T; Sarkis, J; Vannier, E1
Chang, PM; Chen, HL; Hsin, CH; Huang, WS; Lu, HJ; Peng, CY; Tseng, HC; Tseng, SW; Wu, MF; Yang, MH1
Jiang, G; Kang, J; Li, W; Liu, L; Owusu, L; Wang, J; Wang, X; Xu, X; Zhang, C; Zhang, L; Zhou, L1
Alcaraz-Sanabria, A; Burgos, M; Corrales-Sanchez, V; Galan-Moya, EM; Martinez-Canales, S; Montero, JC; Nieto-Jimenez, C; Nuncia-Cantarero, M; Ocaña, A; Pandiella, A1
Chan, MCW; Chen, C; Chen, D; Chen, H; Guo, Z; He, X; Li, J; Li, L; Rao, J; Yang, L; Zhang, LW; Zou, Y1
Hirayama, T; Ikeda, M; Irie, A; Iwamura, M; Koguchi, D; Matsuda, D; Matsumoto, K; Murakami, Y; Okuno, N; Taoka, Y; Utsunomiya, T1
Fujimoto, E; Okame, S; Okazawa-Sakai, M; Shiroyama, Y; Takehara, K; Yokoyama, T1
Bellmunt, J; Hoffman-Censits, J; Kaiser, C; Pal, SK; Tayama, D; Zheng, H1
Chan, C; Colevas, AD; Jiang, W; Kong, C; Le, QT; Lee-Enriquez, N; Murphy, JD; Pinto, H; Tang, C; von Eyben, R1
Angioli, R; De Felice, F; Giorgini, M; Iadarola, R; Lecce, F; Marchetti, C; Monti, M; Musella, A; Muzii, L; Palaia, I; Panici, PB; Perniola, G; Vertechy, L1
Maeda, A; Nakata, M; Nojima, Y; Okita, R; Saisho, S; Shimizu, K; Yukawa, T1
Achatz, MI; Baiocchi, G; da Costa, AA; Guimarães, AP; Mantoan, H; Saito, A; Sanches, S; Valadares, CV1
Abiko, K; Baba, T; Chikuma, S; Hamanishi, J; Honjo, T; Hosoe, Y; Ikeda, T; Kanai, M; Kawaguchi, A; Konishi, I; Mandai, M; Matsumoto, S; Matsumura, N; Minami, M; Mori, Y; Morita, S; Murayama, T; Shimizu, A; Ueda, A; Yamaguchi, K; Yokode, M1
Guancial, E; Iczkowski, KA; Kilari, D; Kim, ES; Messing, EM; Pandya, C; Robin, AJ1
Hanvoravongchai, P; Havanond, P; Khempech, N; Luealon, P; Vasuratna, A1
Abu-Farsakh, SH; Baran, A; Guancial, EA; Kilari, D; Kim, ES; Messing, EM; Xiao, GQ1
Fujitoh, A; Isaka, K; Ito, H; Nishi, H; Sagawa, Y; Yudate, T1
Fujima, N; Fukuda, S; Hatakeyama, H; Homma, A; Kano, S; Mizumachi, T; Oridate, N; Sakashita, T; Suzuki, S; Yoshida, D1
Baldotto, C; Bennouna, J; Ciuleanu, TE; Goksel, T; Gorbunova, V; Le-Guennec, S; Miller, V; Novello, S; Ozguroglu, M; Ramlau, R; Rey, A; Scagliotti, G; Shepherd, FA; Thatcher, N1
Hoshi, S; Mao, H; Nose, M; Orikasa, S; Suzuki, K; Takahashi, T1
Alzieu, C; Cowen, D; Hannoun-Levi, JM; Resbeut, M1
Haga, A; Kito, H; Nagase, H; Sato, T1
Brasnu, D; Hans, S; Laccourreye, H; Laccourreye, O; Ménard, M; Veivers, D1
Matsuyama, H; Sakatoku, J; Shimabukuro, T; Wada, T; Yamamoto, N; Yoshihiro, S1

Reviews

2 review(s) available for platinum and Invasiveness, Neoplasm

ArticleYear
Neoadjuvant immunochemotherapy in the treatment of nonmetastatic muscle-invasive bladder cancer: a systematic review.
    Immunotherapy, 2022, Volume: 14, Issue:17

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Humans; Immunotherapy; Muscles; Neoadjuvant Therapy; Neoplasm Invasiveness; Platinum; Urinary Bladder Neoplasms

2022
Natural history and treatment of malignant thymoma.
    Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:7

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Radiotherapy, Adjuvant; Thymectomy; Thymoma; Thymus Neoplasms

1998

Trials

4 trial(s) available for platinum and Invasiveness, Neoplasm

ArticleYear
Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Experience from an Expanded Access Study in the United States.
    European urology, 2018, Volume: 73, Issue:5

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma, Transitional Cell; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Platinum; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome; United States; Urologic Neoplasms

2018
Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution Experience.
    Annals of surgical oncology, 2015, Volume: 22, Issue:13

    Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Survival Rate

2015
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Dec-01, Volume: 33, Issue:34

    Topics: Adenocarcinoma, Clear Cell; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Cohort Studies; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Nivolumab; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Prognosis; Programmed Cell Death 1 Receptor; Salvage Therapy; Survival Rate

2015
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Oct-10, Volume: 30, Issue:29

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Prognosis; Proportional Hazards Models; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Risk Assessment; Survival Analysis; Taxoids; Treatment Outcome

2012

Other Studies

20 other study(ies) available for platinum and Invasiveness, Neoplasm

ArticleYear
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.
    Molecular cancer therapeutics, 2022, 05-04, Volume: 21, Issue:5

    Topics: Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Platinum; Spironolactone; Urinary Bladder Neoplasms

2022
Bladder preservation in older adults with muscle-invasive bladder cancer: A retrospective study with concurrent chemotherapy and twice-daily hypofractionated radiotherapy schedule.
    Journal of geriatric oncology, 2022, Volume: 13, Issue:7

    Topics: Aged; Combined Modality Therapy; Cystectomy; Fluorouracil; Humans; Muscles; Neoplasm Invasiveness; Organ Sparing Treatments; Platinum; Retrospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms

2022
Predictors of early progression after curative resection followed by platinum-based adjuvant chemoradiotherapy in oral cavity squamous cell carcinoma.
    Postgraduate medicine, 2021, Volume: 133, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Disease Progression; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis

2021
Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:19

    Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Furans; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Phenanthrenes; Phosphatidylinositol 3-Kinases; Platinum; Proto-Oncogene Proteins c-akt; Quinones; Signal Transduction; Transcription, Genetic; Zebrafish

2020
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
    International journal of molecular sciences, 2020, Nov-27, Volume: 21, Issue:23

    Topics: Apoptosis; Breast Neoplasms; Carboplatin; Caspases; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Cisplatin; Deoxycytidine; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Humans; Neoplasm Invasiveness; Platinum

2020
Mitochondria-targeted platinum(ii) complexes: dual inhibitory activities on tumor cell proliferation and migration/invasion via intracellular trafficking of β-catenin.
    Metallomics : integrated biometal science, 2017, 06-21, Volume: 9, Issue:6

    Topics: A549 Cells; Animals; Antineoplastic Agents; beta Catenin; Breast Neoplasms; Cell Adhesion; Cell Movement; Cell Proliferation; Female; Hep G2 Cells; Humans; Mice; Mitochondria; Neoplasm Invasiveness; Platinum; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2017
Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study.
    Clinical genitourinary cancer, 2018, Volume: 16, Issue:3

    Topics: Aged; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nephrectomy; Patient Selection; Platinum; Prognosis; Retrospective Studies; Urologic Neoplasms

2018
Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
    International journal of clinical oncology, 2018, Volume: 23, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Platinum; Postoperative Care; Prognosis; Retrospective Studies; Survival Rate; Taxoids; Uterine Cervical Neoplasms; Young Adult

2018
Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer.
    Head & neck, 2015, Volume: 37, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Treatment Outcome

2015
Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
    World journal of surgical oncology, 2015, Feb-06, Volume: 13

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyclooxygenase 2; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate; Tegafur

2015
Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer.
    Annals of surgical oncology, 2015, Volume: 22 Suppl 3

    Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Risk Factors; Survival Rate

2015
Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients.
    Anticancer research, 2016, Volume: 36, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cation Transport Proteins; Copper Transporter 1; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Prognosis; Urinary Bladder Neoplasms

2016
Cost Effectiveness Analysis of Different Management Strategies between Best Supportive Care and Second-line Chemotherapy for Platinum-resistant or Refractory Ovarian Cancer.
    Asian Pacific journal of cancer prevention : APJCP, 2016, Volume: 17, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Quality-Adjusted Life Years; Salvage Therapy; Survival Rate; Topotecan

2016
Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    PloS one, 2016, Volume: 11, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Treatment Outcome; Urinary Bladder Neoplasms

2016
Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2011, Volume: 32, Issue:2

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Mitomycin; Neoplasm Invasiveness; Platinum

2011
Platinum concentration in sentinel lymph nodes after preoperative intra-arterial cisplatin chemotherapy targeting primary tongue cancer.
    Acta oto-laryngologica, 2012, Volume: 132, Issue:10

    Topics: Adult; Aged, 80 and over; Cisplatin; Female; Follow-Up Studies; Glossectomy; Humans; Infusions, Intra-Arterial; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Platinum; Preoperative Care; Risk Assessment; Sampling Studies; Sentinel Lymph Node Biopsy; Tongue Neoplasms; Treatment Outcome

2012
Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer.
    International journal of urology : official journal of the Japanese Urological Association, 1997, Volume: 4, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Lung Neoplasms; Male; Neoplasm Invasiveness; Platinum; Rabbits; Urinary Bladder Neoplasms

1997
Inhibition effect of propargylglycine on human fibrosarcoma HT-1080 cell invasiveness.
    Cancer biochemistry biophysics, 1998, Volume: 16, Issue:1-2

    Topics: Alkynes; Cadmium; Chemotaxis; Collagen; Copper; Dose-Response Relationship, Drug; Drug Combinations; Fibronectins; Fibrosarcoma; Glycine; Humans; Laminin; Metallothionein; Neoplasm Invasiveness; Platinum; Proteoglycans; Time Factors; Tumor Cells, Cultured

1998
Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders.
    Cancer, 2001, Sep-15, Volume: 92, Issue:6

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Second Primary; Pharyngeal Neoplasms; Platinum; Salvage Therapy

2001
[Angiographic analysis of intratumoral Pt concentration on intra-arterial infusion therapy for bladder cancer].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1991, Volume: 82, Issue:7

    Topics: Aged; Angiography; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Invasiveness; Platinum; Regional Blood Flow; Urinary Bladder; Urinary Bladder Neoplasms

1991